QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

PURPOSE: Hydroxychloroquine, chloroquine, and azithromycin have been used for treatment of COVID-19, but may cause QT prolongation. Minority populations are disproportionately impacted by COVID-19. This study evaluates the risk of QT prolongation and subsequent outcomes after administration of these...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Interv Card Electrophysiol
Autori principali: Hsia, Brian C, Greige, Nicolas, Quiroz, Jose A, Khokhar, Ahmed S, Daily, Johanna, Di Biase, Luigi, Ferrick, Kevin J, Fisher, John D, Krumerman, Andrew
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352082/
https://ncbi.nlm.nih.gov/pubmed/32654098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10840-020-00822-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi